Abstract: Presented are systems and methods that analyze an individual's state based on selected criteria, and then adaptively provide stimuli to affect the individual's performance compared to established benchmarks and pre-set plans. The methods or systems can provide audio and/or tactile inputs to a human subject to obtain a specific performance state. A music or sound selection engine considers the sensory and environmental inputs and selects the appropriate music or auditory stimulus, with the intent to reach a desired state of flow. The methods and systems can employ multiple measurements of personal data that can correlate to the emotional state of a subject. By manipulating stimuli delivered to an individual, ultimate performance can be improved over various planning horizons.

Abstract: Presented are systems and methods that analyze an individual's state based on selected criteria, and then adaptively provide stimuli to affect the individual's performance compared to established benchmarks and pre-set plans. The methods or systems can provide audio and/or tactile inputs to a human subject to obtain a specific performance state. A music or sound selection engine considers the sensory and environmental inputs and selects the appropriate music or auditory stimulus at 14, with the intent to reach desired state of flow. The methods an systems can employ multiple measurements of personal data that can correlate to the emotional state of a subject. By manipulating stimuli delivered to an individual, ultimate performance can be improved over various planning horizons.

Abstract: Antibodies to SEB, fragments thereof, and compositions comprising such are provided. Therapies for staphylococcal infection are provided, as well as assays for identifying additional agents useful in such therapies. An isolated antibody, or an isolated antigen-binding fragment of an antibody, is provided which antibody or antigen-binding fragment binds to staphylococcal enterotoxin B (SEB) and which antibody or antigen-binding fragment comprises a heavy chain variable CDR3 comprising the sequence RIYYGNNGGVMDY (SEQ ID NO:30); ARTAGLLAPMDY (SEQ ID NO:31); ARDTMRKCYCELKLKPPAEHPGPA (SEQ ID NO:32) or VRDL YGDYVGRY A Y (SEQ ID NO:48).

Abstract: Antibodies to SEB, fragments thereof, and compositions comprising such are provided. Therapies for staphylococcal infection are provided, as well as assays for identifying additional agents useful in such therapies. An isolated antibody, or an isolated antigen-binding fragment of an antibody, is provided which antibody or antigen-binding fragment binds to staphylococcal enterotoxin B (SEB) and which antibody or antigen-binding fragment comprises a heavy chain variable CDR3 comprising the sequence RIYYGNNGGVMDY (SEQ ID NO:30); ARTAGLLAPMDY (SEQ ID NO:31); ARDTMRKCYCELKLKPPAEHPGPA (SEQ ID NO:32) or VRDL YGDYVGRY A Y (SEQ ID NO:48).